Ewing sarcoma/primitive neuroectodermal tumor with chondroid differentiation

a potential diagnostic pitfall

Autores

  • Maria Carolina Martins Mussi Universidade Federal do Oeste da Bahia https://orcid.org/0000-0002-7616-2845
  • Fernanda Mombrini Pigatti Universidade Federal de Juiz de Fora
  • Priscila Lie Tobouti Universidade de São Paulo
  • Bruno Tavares Sedassar Universidade Nove de Julho
  • Decio dos-Santos Pinto Junior Universidade de São Paulo
  • Suzana Cantanhede Orsini Machado de Sousa Universidade de São Paulo

DOI:

https://doi.org/10.5935/2525-5711.20210006

Palavras-chave:

Ewing sarcoma, Primitive neuroectodermal tumor, Molecular Pathology

Resumo

Ewing sarcoma/Primitive neuroectodermal tumor (ES/PNET) with chondroid differen- tiation and mesenchymal chondrosarcoma (MSC) have similar histopathological features. It may be difficult to distinguish both lesions without genetic or molecular analysis. The main aim of this case report is to highlight the difficulty in establishing the diagnosis of ES/ PNET with areas of chondroid differentiation. A 14-year-old female patient with painful right mandibular swelling. Imaging exams showed an extensive osteolytic lesion with mineralized areas. Histomorphologic and immunohistochemistry studies were performed. In situ hybridization was necessary to confirm the diagnosis. Immunohistochemistry and H&E-stained sections did not provide sufficient evidence to differentiate ES/PNET from MCS. The genetic tool demonstrated EWS1 gene breakpoint. ES/PNET with chondroid differentiation is rare and new studies are necessary to standardize molecular biomarkers and/or the panel of antibodies required to differentiate ES/PNET from MCS.

Biografia do Autor

Maria Carolina Martins Mussi, Universidade Federal do Oeste da Bahia

Universidade Federal do Oeste da Bahia, Department of Pathology

Fernanda Mombrini Pigatti, Universidade Federal de Juiz de Fora

Universidade Federal de Juiz de Fora, Dental School, Department of Stomatology and Clinic

Priscila Lie Tobouti, Universidade de São Paulo

Universidade de São Paulo, Dental School, Department of Pathology

Bruno Tavares Sedassar, Universidade Nove de Julho

Universidade Nove de Julho, Medical School, Department of Pathology

Decio dos-Santos Pinto Junior, Universidade de São Paulo

Universidade de São Paulo, Dental School, Department of Pathology

Suzana Cantanhede Orsini Machado de Sousa, Universidade de São Paulo

Universidade de São Paulo, Dental School, Department of Pathology

Referências

Machado I, Navarro S, Llombart-Bosch A. Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review. Histol Histopathol [Internet]. 2016 Nov; [cited 2020 Dec 27]; 31(11):1169-81. Available from: https://pubmed.ncbi.nlm.nih.gov/27306060/

Davido N, Rigolet A, Kerner S, Gruffaz F, Boucher Y. Case of Ewing's sarcoma misdiagnosed as a periapical lesion of maxillary incisor. J Endod [Internet]. 2011 Feb; [cited 2020 Dec 27]; 37(2):259-64. Available from: https://pubmed.ncbi.nlm.nih.gov/21238814/

Granter SR, Renshaw AA, Fletcher CD, Bhan AK, Rosenberg AE. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol. 1996 Dec;27(12):1273-6.

Xu J, Li D, Xie L, Tang S, Guo W. Mesenchymal chondrosarcoma of bone and soft tissue: a systematic review of 107 patients in the past 20 years. PLoS One. 2015 Apr;10(4):e0122216.

Roberts F, MacDuff EM. An update on mesenchymal tumours of the orbit with an emphasis on the value of molecular/cytogenetic testing. Saudi J Ophthalmol. 2018 Jan/Mar;32(1):3-12.

Stewart BD, Reith JD, Knapik JA, Chi AC. Bone- and cartilage-forming tumors and ewing sarcoma: an update with a gnathic emphasis. Head Neck Pathol. 2014 Dec;8(4):454-62.

Llombart-Bosch A, Machado I, Navarro S, Bertoni F, Bacchini P, Alberghini M, et al. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch. 2009 Nov;455(5):397-411.

Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP. Ewing sarcoma and Ewing-like tumors. Virchows Archiv. 2020 Dec;476:109-19. DOI: https://doi.org/10.1007/s00428-019-02720-8

Xie L, Wang H, Xiang J, Xu R. Massive osseous and cartilaginous metaplasia of soft tissue Ewing sarcoma in adult: report of two cases. Histopathology. 2015 Sep;67(3):417-20.

Kodama K, Doi O, Higashiyama M, Yokouchi H, Tateishi R, Mori Y. Differentiation of a Ewing's sarcoma cell line towards neural and mesenchymal cell lineages. Jpn J Cancer Res. 1994 Apr;85(4):335-8.

Merkes C, Turkalo TK, Wilder N, Park H, Wenger LW, Lewin SJ, et al. Ewing sarcoma ewsa protein regulates chondrogenesis of Meckel's cartilage through modulation of Sox9 in zebrafish. PLoS One. 2015 Jan;10(1):e0116627.

Gelderblom H, Hogendoorn PCW, Dijkstra SD, Van Rijswijk CS, Krol AD, Taminiau AHM, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008 Mar;13(3):320-9.

Hung YP, Fletcher CDM, Hornick JL. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Mod Pathol. 2016 Apr;29(4):370-80.

Cajaiba MM, Luo J, Goodman MA, Fuhrer KA, Rao UNM. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas. Int J Surg Pathol. 2010 Oct;18(5):319-23.

Desai SS, Jambhekar NA. Pathology of Ewing's sarcoma/PNET: current opinion and emerging concepts. Indian J Orthop. 2010 Oct/Dec;44(4):363-8.

Riggi N, Stamenkovic I. The biology of Ewing sarcoma. Cancer Lett. 2007 Aug;254(1):1-10.

Downloads

Publicado

2021-01-08

Como Citar

1.
Mussi MCM, Pigatti FM, Tobouti PL, Sedassar BT, Pinto Junior D dos-S, Sousa SCOM de. Ewing sarcoma/primitive neuroectodermal tumor with chondroid differentiation: a potential diagnostic pitfall. J Oral Diagn [Internet]. 8º de janeiro de 2021 [citado 21º de setembro de 2024];6:1-4. Disponível em: https://jordi.com.br/revista/article/view/50

Edição

Seção

Relato de Caso